perfusion assessment in chronic wounds - asps...objectively proven arterial occlusive disease....

57
Perfusion Assessment in Chronic Wounds Michael Maier, DPM, FACCWS Cardiovascular Medicine Cleveland Clinic American Society of Podiatric Surgeons Surgical Conference September 22, 2018

Upload: others

Post on 14-Jun-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Perfusion Assessment in Chronic

Wounds

Michael Maier, DPM, FACCWS

Cardiovascular Medicine

Cleveland Clinic

American Society of Podiatric Surgeons

Surgical Conference

September 22, 2018

Page 2: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Disclosures

Speaker, Smith & Nephew

Speaker, KCI

Consultant, WNDM Medical

Consultant, Medtronic

Page 3: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

OBJECTIVES

• Describe traditional vascular laboratory studies to

assess arterial circulation

• Discuss limitations of non-anatomic perfusion

assessment

• Compare and contrast non-invasive perfusion

assessment strategies

Page 4: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

PAD Clinical Presentations

• Asymptomatic: 20 – 50%

• Classic Claudication: 10 – 35%

• Atypical Leg Pain: 40 – 50%

• Critical Limb Ischemia (CLI): 1 – 3%

McDermott et al. JAMA 2001;286:1599.

Page 5: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Critical Limb Ischemia (CLI)

Definition

• Critical limb ischemia (CLI) A condition characterized by

chronic (≥2 weeks) ischemic rest pain, nonhealing

wound/ulcers, or gangrene in 1 or both legs attributable to

objectively proven arterial occlusive disease.

Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the

management of patients with lower extremity peripheral artery disease: executive summary:

a report of the American College of Cardiology/American Heart Association Task Force on

Clinical Practice Guidelines. J Am Coll Cardiol 2017; 69: pp. 1465-1508.

Page 6: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Critical Limb Ischemia (CLI)

Definition

• The diagnosis of CLI is a constellation of both symptoms

and signs. Arterial disease can be proved objectively with

ABI, TBI, TcPO2, or skin perfusion pressure.

Supplementary parameters, such as absolute ankle and

toe pressures and pulse volume recordings, may also be

used to assess for significant arterial occlusive disease.

However, a very low ABI or TBI does not necessarily

mean the patient has CLI.

Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the

management of patients with lower extremity peripheral artery disease: executive summary:

a report of the American College of Cardiology/American Heart Association Task Force on

Clinical Practice Guidelines. J Am Coll Cardiol 2017; 69: pp. 1465-1508.

Page 7: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

CLI – Clinical Definition

Fontaine Classification

Stage I

• Asymptomatic

Stage II

• IIa – Claudication > 200m

• IIb – Claudication < 200m

Stage III

• Rest pain

Stage IV

• Ischemic ulcers or gangrene

Rutherford Classification

Stage 0

• Asymptomatic

Stages 1, 2, 3

• Mild, moderate, severe claudication

Stage 4

• Rest pain

Stage 5

• Digital ischemic ulcers

Stage 6

• Severe ischemic ulcers or gangrene

TASC Document J Vasc Surg; 2000:S170

Page 8: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

CLI – Hemodynamic Definition

• Ankle pressure < 50 – 70 mmHg

• ABI < 0.4

• Toe pressure < 30 – 50 mmHg

• TcPO2 < 30 – 50 mmHg

TASC Document J Vasc Surg; 2000:S170

Page 9: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Critical Limb Ischemia

Dependent rubor

GangreneTissue loss

Page 10: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Hand held Doppler/ABI

Segmental Pressures +/- PVR’s

Arterial Duplex Ultrasound

TcPO2/Laser Doppler

“Advanced Imaging”

ABI = ankle-brachial index; PVR = pulse volume recording; TcPO2 = transcutaneous oximetry

Gerha. Echocardiogr. 2006;19:955-972. rd-Herman M, et al. J Am Soc; Gahtan V. Surg Clin North Am. 1998;78(4):507-518.

Arterial Evaluation

Page 11: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Continuous Wave Doppler

• Hand held Doppler

• Measures high-velocity blood flow

• Uses separate crystals to send and receive

ultrasound signals of a single frequency

• Lacks depth precision (pulsed wave Doppler

is more “location sensitive”)

• Triphasic, biphasic, monophasic

Page 12: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Ankle Brachial Index (ABI)

• Measure ankle and brachial (arm) systolic

pressures with handheld Doppler device

• Use highest arm and each ankle pressure

Dormandy JA, Rutherford RB, for the TASC Working Group. J Vasc Surg. 2003;31(1pt 2):S1

Ankle systolic pressure

Highest systolic brachial pressureABI =

Page 13: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

ABI

0.91 - 1.40 Normal

0.70 - 0.90 Mild disease

0.40 - 0.69 Moderate disease

0.00 - 0.39 Severe disease

• ABI >1.4 is abnormal and consistent with calcified vessels – unreliable

• ABI < 0.4 = Critical Limb Ischemia (ankle pressure < 50 – 70 mmHg)

• ABI alone is inadequate to assess distal perfusion

Newman AB, et al. Circulation. 1993;88:837-845.

Page 14: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

ABI Limitations

• ABI may be elevated in patients with non-compressible arteries (diabetes, ESRD)

• Resting ABI is insensitive to mild aorto-iliac occlusive disease

• Normal resting values in symptomatic patients may become abnormal after exercise

• ABI correlates poorly with functional status

Page 15: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

ABI Limitations

• 89 consecutive patients with CLI had non-invasive testing for

indications of rest pain (n=23, 26%), as well as minor (n=29, 33%)

and major (n=37, 42%) ischemic tissue loss.

• All patients subsequently underwent ABI testing and lower extremity

angiography with visualization of the infragenicular arteries.

• Toe–brachial index (TBI) testing was available among 31 of these

patients.

Bunte M.C., Jacob J., Nudelman B., and Shishehbor M.H.: Validation

of the relationship between ankle-brachial and toe-brachial indices

and infragenicular arterial patency in critical limb ischemia. Vasc Med

2015; 20: pp. 23-29.

Page 16: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Bunte M.C., Jacob J., Nudelman B., and Shishehbor M.H.: Validation

of the relationship between ankle-brachial and toe-brachial indices

and infragenicular arterial patency in critical limb ischemia. Vasc Med

2015; 20: pp. 23-29.

Page 17: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

ABI Limitations

• Nearly one-third of patients with any ischemic tissue loss/CLI had a

normal or mildly reduced ABI.

• Assessment of TBI may augment the diagnostic accuracy of ABI in

the evaluation of CLI.

Bunte M.C., Jacob J., Nudelman B., and Shishehbor M.H.: Validation

of the relationship between ankle-brachial and toe-brachial indices

and infragenicular arterial patency in critical limb ischemia. Vasc Med

2015; 20: pp. 23-29.

Page 18: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

TBI = Toe Brachial Index

• Useful in individuals with non-

compressible pedal pulses

• Helps to assess distal perfusion,

especially for patients with foot

ulceration

• TBI ≥ 0.7 is normal

• Critical Limb Ischemia = Toe

pressure < 30 – 50 mmHg

TASC Document J Vasc Surg; 2000:S170

Page 19: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the

management of patients with lower extremity peripheral artery disease: executive summary:

a report of the American College of Cardiology/American Heart Association Task Force on

Clinical Practice Guidelines. J Am Coll Cardiol 2017; 69: pp. 1465-1508.

Page 20: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Segmental Pressures/PVR

• Segmental pressures and plethysmographic waveforms

used for analysis

• Compares blood pressure measurements at multiple sites

• Segmental pressure drop of >20 mmHg between

segments is consistent with obstruction

• Metatarsal and toe or digital PPG can help evaluate small

vessel perfusion

PPG = photoplethysmograph Rutherford, Vascular Surgery, 7th Edition, 2010.

Page 21: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Segmental Blood Pressures

• Localizes level of disease

– Aortoiliac

– Common femoral/profunda

– Superficial femoral/popliteal

– Tibial vessel/infra-popliteal

– Small vessel

• Waveforms are also used to

interpret disease in the setting of

calcified vessels (diabetes/ESRD)

ESRD = end-stage renal disease Rutherford, Vascular Surgery, 7th Edition, 2010.

Page 22: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Transcutaneous Oximetry/TcPO2

• Measures oxygen tension 1-2 mm deep in the skin from the local capillary (nutritive) perfusion

• Useful for wound healing prediction in extremities

• Can be used to assess response to HBOT

Fife CE, et al. Journal Of Undersea and Hyperbaric Medicine. 2009;36:43-53.

HBOT = hyperbaric oxygen therapy

Page 23: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Transcutaneous Oximetry/TcPO2

• TcPO2 > 70 mm Hg = Normal Value

• TcPO2 < 40 mm Hg = Impaired Wound Healing

• TcPO2 < 30 mm Hg = Critical Limb Ischemia

• Low values of TcPO2 (< 40 mmHg)– Peripheral artery disease

– High altitude

– Pulmonary disease

– Heart failure

– Edema

– Inflammation

– Callous, skin diseases (scleroderma)

Fife CE, et al. Journal Of Undersea and Hyperbaric Medicine. 2009;36:43-53.

Page 24: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Transcutaneous Oximetry/TcPO2

Page 25: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Regional Perfusion Assessment

Page 26: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Skin Perfusion Pressure (SPP)

• Measurement (mmHg) of the capillary opening pressure after occlusion

• Uses blood pressure cuffs to occlude blood flow, followed by controlled pressure release allowing gradual return of blood flow

• During cuff deflation, laser Doppler is used to determine return of blood flow (reactive hyperemia)

• The pressure at which movement is detected is the skin perfusion pressure

Lo T, et al. Wounds 2009; 21(11);310-316.

Page 27: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Sender Receiver

Laser Doppler and SPP

• The laser Doppler probe emits and

detects light scattered in the tissue

• Light hitting moving blood cells will

cause a change in frequency

= Doppler shift

• An algorithm converts the optical information into SPP by:– Capturing the onset of capillary flow return

– Determining pressure (mmHg) at which return flow onset occurs

Lo T, et al. Wounds 2009; 21(11);310-316.

Page 28: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Laser Doppler and SPP

SPP Interpretation Guideline (mmHg)

50 or > = Normal skin perfusion

40 – 50 = Mild ischemia

40 + = Wound healing probable/mild to moderate ischemia

30 – 40 = Gray zone for healing/moderate ischemia

30 or < = Wound healing unlikely/Critical Limb Ischemia

Lo T, et al. Wounds 2009; 21(11);310-316.

Page 29: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

SPP vs. TcPO2

• SPP measures pressure (mmHg)

• TcPO2 measures oxygen molecules (mmHg)

• SPP Advantages

– Not affected by vessel calcification, callous or thickened

skin, or edema and can be used on plantar foot and digits

– Generally more sensitive in its ability to predict wound

healing relative to TcPO2

• SPP Disadvantages

– Not useful for predicting response to HBOT

– Blood flow occlusion of the cuff may be painful

– Patients must lie supine with legs extended

Lo T, et al. Wounds 2009; 21(11);310-316.

Page 30: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Arterial Duplex Ultrasound

• Measures velocity of blood flow and visualizes arterial structure

• Provides anatomic information with no contrast

• May help in determining interventional strategies

Alexander JQ. Am Surg. 2002;68:1107-1110.

Page 31: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Arterial Duplex Ultrasound

• Accurate and well-accepted method for assessing peripheral arterial system pre- and post-operatively

• Sensitivity, 97%; specificity, 96%; positive predictive value, 95%; negative predictive value, 98%; overall accuracy, 96% relative to contrast angiography

Alexander JQ. Am Surg. 2002;68:1107-1110.

Page 32: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

• 62 year old man

• Brittle diabetes, HTN, HL,

borderline CKD (CR 1.4)

• Non-traumatic right BKA

• Calcaneal osteomyelitis

• Treated with IV antibiotics

• Aggressive wound treatment

– HBOT

Page 33: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

TcPO2

Page 34: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

ABI: 1.17

TBI: 0.21

ABI: 0.69

Page 35: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Angiosome Approach to Perfusion

Page 36: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

3 weeks 7 weeks 10 weeks

Clinical Course

Page 37: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Pre-intervention Post-intervention

Page 38: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

2 Weeks Post-intervention

Sharp debridement

Initiate enzymatic debridement

6 Weeks Post-intervention

Page 39: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

14 Weeks Post-intervention10 Weeks Post-intervention

Continue enzymatic debridement

Initiate NPWT 125mmHg

(continuous)

Page 40: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

22 Weeks Post-intervention19 Weeks Post-intervention

Hold enzymatic debridement

Initiate sequential tissue grafts

Page 41: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

35 Weeks Post-intervention

Page 42: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

• 82 year diabetic lady with bilateral midfoot collapse due

to Charcot arthropathy and partial 1st ray amputations

• Presents with left midfoot ulceration x 1 month

Page 43: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

ABI: 0.56

Page 44: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Left popliteal artery intervention

Page 45: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

ABI: 1.12

ABI: 0.56

Page 46: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

• Post-intervention sharp and enzymatic debridement

• Non-weight bearing

Page 47: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

3 weeks later…

Page 48: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

7 Weeks Post-Intervention

12 Weeks Post-Intervention

Page 49: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Angiosome Approach to Perfusion

Page 50: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management
Page 51: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management
Page 52: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

4 Weeks Post-Repeat Intervention

8 Weeks Post-Repeat Intervention

Page 53: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

16 Weeks

Post-Repeat Intervention

21 Weeks

Post-Repeat Intervention

Page 54: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

1 Year Follow Up

Page 55: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Conclusions

• Utilize screening ABI’s, but recognize

limitations for detecting PAD/CLI

• Include TBI’s to augment the

diagnostic accuracy of ABI’s

• Consider TcPO2 and SPP as adjunct

perfusion assessment tools

• Recognize CLI is a medical urgency

that requires a team approach

Page 56: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Thank You

Page 57: Perfusion Assessment in Chronic Wounds - ASPS...objectively proven arterial occlusive disease. Gerhard-Herman M.D., Gornik H.L., Barrett C., et al: 2016 AHA/ACC Guideline on the management

Perfusion Assessment in Chronic

Wounds

Michael Maier, DPM, FACCWS

Cardiovascular Medicine

Cleveland Clinic

American Society of Podiatric Surgeons

Surgical Conference

September 22, 2018